GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Pretax Margin %

Biolife Sciences (Biolife Sciences) Pretax Margin % : -46.83% (As of May. 2008)


View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Biolife Sciences's Pre-Tax Income for the three months ended in May. 2008 was $-0.84 Mil. Biolife Sciences's Revenue for the three months ended in May. 2008 was $1.80 Mil. Therefore, Biolife Sciences's pretax margin for the quarter that ended in May. 2008 was -46.83%.

The historical rank and industry rank for Biolife Sciences's Pretax Margin % or its related term are showing as below:


BLFE's Pretax Margin % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: -0.89
* Ranked among companies with meaningful Pretax Margin % only.

Biolife Sciences Pretax Margin % Historical Data

The historical data trend for Biolife Sciences's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Pretax Margin % Chart

Biolife Sciences Annual Data
Trend Nov04 Nov05 Nov06 Nov07
Pretax Margin %
- -25,100.00 -4.51 -23.78

Biolife Sciences Quarterly Data
Nov04 Feb05 May05 Aug05 Nov05 Feb06 May06 Aug06 Nov06 Feb07 May07 Aug07 Nov07 Feb08 May08
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.18 -16.13 -44.37 -30.16 -46.83

Competitive Comparison of Biolife Sciences's Pretax Margin %

For the Medical Instruments & Supplies subindustry, Biolife Sciences's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biolife Sciences's Pretax Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biolife Sciences's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Biolife Sciences's Pretax Margin % falls into.



Biolife Sciences Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Biolife Sciences's Pretax Margin for the fiscal year that ended in Nov. 2007 is calculated as

Pretax Margin=Pre-Tax Income (A: Nov. 2007 )/Revenue (A: Nov. 2007 )
=-2.046/8.603
=-23.78 %

Biolife Sciences's Pretax Margin for the quarter that ended in May. 2008 is calculated as

Pretax Margin=Pre-Tax Income (Q: May. 2008 )/Revenue (Q: May. 2008 )
=-0.842/1.798
=-46.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Biolife Sciences  (OTCPK:BLFE) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Biolife Sciences Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biolife Sciences (Biolife Sciences) Business Description

Traded in Other Exchanges
N/A
Address
2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052
Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.
Executives
Arthur Viola director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired 09-15-2020